Resistance to therapy caused by intragenic deletion in BRCA2

Nature

Volumn 451, Issue 7182, 2008, Pages 1111-1115

  Edwards, Stacey L ^a   Brough, Rachel ^a   Lord, Christopher J ^a   Natrajan, Rachael ^a   Vatcheva, Radost ^a   Levine, Douglas A ^b   Boyd, Jeff ^c   Reis Filho, Jorge S ^a   Ashworth, Alan ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c MEMORIAL HEALTH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; CARBOPLATIN; DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); RAD51 PROTEIN;

ALLELE; CANCER; CYTOLOGY; DRUG RESISTANCE; ENZYME ACTIVITY; GENE EXPRESSION; GENOTOXICITY; INHIBITION; MUTATION; RECOMBINATION; TUMOR;

ARTICLE; CANCER CELL CULTURE; CELL NUCLEUS; CLONE; CONTROLLED STUDY; CULTURE MEDIUM; DNA DAMAGE; DNA REPAIR; FRAMESHIFT MUTATION; GENE DELETION; GENE SEQUENCE; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; SEQUENCE HOMOLOGY; TUMOR SUPPRESSOR GENE;

EID: 39849097680     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature06548     Document Type: Article

References (30)